Slocum, Gordon & CO LLP Amgen Inc Transaction History
Slocum, Gordon & CO LLP
- $127 Million
- Q1 2025
A detailed history of Slocum, Gordon & CO LLP transactions in Amgen Inc stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 562 shares of AMGN stock, worth $163,497. This represents 0.14% of its overall portfolio holdings.
Number of Shares
562
Previous 1,125
50.04%
Holding current value
$163,497
Previous $293,000
40.27%
% of portfolio
0.14%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,241Shares Held
422MCall Options Held
7.04MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$15.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.4 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.56 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.24 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.84 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $156B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...